Login
Testing & Analysis
INVESTIGATIVE REPORT REVEALS PUBLIC HEALTH AND ECONOMIC CONSEQUENCES OF NEW YORK’S UNREGULATED POP-UP CANNABIS MARKET
Coli, Lead, Salmonella & Other Contaminants Found In ‘Pop-Up’ & Illegal Dispensary Products; Mislabeling & Youth-Targeted Branding Abound, Putting Consumers At Risk, Threatening Success Of NY’s Equity-Based Adult-Use Program New York, November 30, 2022 – New York has laid the groundwork for the nation’s most equitable adult-use cannabis industry. However, while the nascent industry holds …
PathogenDx Debuts Octa™ AutoPrep Station: A Simple, Easy-to-Use Automated Sample Prep Solution for the Cannabis and Hemp Testing Sector
Supporting the Company’s Suite of Compatible AOAC-Certified Assays, the Octa™AutoPrep Station Delivers 73% Lower Labor Costs, Up to 8x Less Consumable Waste Octa™ AutoPrep Station to Launch in the Food and Environmental Testing Sectors Next Year November XX, 2022 (Scottsdale, Arizona) – PathogenDx, a leader in next-generation microarray technology for better health and safety, …
Cannabis Marketing: Ultimate Guide for Commercial Growers
In order to be successful in the cannabis industry, cultivation brands and businesses need to have a well-developed cannabis marketing plan. A marketing strategy can include any number of initiatives and channels. Featured in this article are the top five essential components for a cannabis cultivator: branding, website, search engine optimization (SEO), public relations, and …
Cannabis Marketing: Ultimate Guide for Commercial Growers Read More »
Automation and innovative design of BUCHI’s new Spray Dryer markedly improve spray drying performance
June 2022, Flawil, Switzerland – BUCHI Labortechnik, the global market leader in spray drying equipment for the last 40 years, has launched the Mini Spray Dryer S-300, a new generation of spray drying systems. The latest instrument combines novel automation capabilities and innovative system design for unmatched efficiency, reproducibility and safety during the spray drying …
Feds Loosen Grip on Cannabis
Royal Emerald Pharmaceuticals (REP) Receives Federal Licenses for Cannabis Research
Desert Hot Springs, California, USA (January 18, 2022) – Royal Emerald Pharmaceuticals (REP) is proud to announce that it has received four federal licenses to grow, research, develop, and manufacture alternative drugs derived from cannabis (marijuana) and other botanicals in December 2021. REP is the first-of-its-kind cannabis pharmaceutical company in the United States to receive these highly coveted licenses.